ARTICLE | Clinical News
Briviact brivaracetam regulatory update
January 25, 2016 8:00 AM UTC
UCB said the European Commission approved Briviact brivaracetam as an adjunct therapy to treat partial-onset seizures in epileptics ages >=16. The company plans to launch Briviact this quarter in sele...